Platelet factor 4 (PF4) was significantly reduced in plasma of CKD5D patients, whereas glycocalicin—the soluble form of the GPIbα receptor (binding to von Willebrand factor)—was unaltered in CKD (Supplemental Figures S8A and S8B). Here, PF4 is linked to chronic kidney disease.